Skip to main content
. Author manuscript; available in PMC: 2021 Aug 1.
Published in final edited form as: Cancer Cytopathol. 2020 Apr 3;128(8):528–534. doi: 10.1002/cncy.22267

Table 1.

Cytology and HPV ASC-US Triage Testing in the Study Population

Total
N (%)
White
n (%)
Black
n (%)
Other
n (%)

Total N (%)
43,106
(100)
11,681
(27.1)
26,941
(62.5)
4,484
(10.4)

Unsatisfactory
293
(0.7)
113
(1.0)
142
(0.5)
38
(0.9)

NILM
34,363
(80.2)
9,159
(79.0)
21,343
(79.7)
3,861
(86.4)
         

ASC-US
4,672
(10.9)
1,250
(10.8)
3,070
(11.5)
352
(7.9)

HPV negative
1,786
(4.1)
537
(4.6)
1,191
(4.4)
58
(1.2)

HPV positive
2,482
(5.7)
655
(5.6)
1,766
(6.5)
61
(1.4)

HPV Untested
404
(0.9)
59
(0.5)
108
(0.4)
233
(5.2)
       

LSIL
2,683
(6.3)
779
(6.7)
1,724
(6.4)
180
(4.0)

ASC-H
187
(0.4)
55
(0.5)
118
(0.4)
14
(0.3)

HSIL
633
(1.5)
230
(2.0)
382
(1.4)
21
(0.5)

AGC
22
(0.1)
7
(0.1)
13
(0.1)
2
(0.04)

Cytology Missing
253
(0.6)
88
(34.8)
149
(58.9)
16
(6.3)

Abbreviations:

NILM – Negative for Intraepithelial Lesion or Malignancy

ASC-US – Atypical Squamous Cells of Undetermined Significance

LSIL – Low Grade Squamous Intraepithelial Lesion

ASC-H – Atypical Squamous Cells of Undetermined Significance High Grade

HSIL – High Grade Squamous Intraepithelial Lesion

AGC- Atypical Glandular Cells

HPV Untested – women without an HPV test result